U.S. Senators John Fetterman (D-PA) and Dave McCormick (R-PA) issued a joint letter urging the National Institutes of Health to accelerate funding disbursements.
The bipartisan effort highlights a rare moment of cooperation between the two Pennsylvania senators on issues of federal efficiency and economic development. By targeting the speed of congressionally appropriated funds, the lawmakers aim to ensure that approved research and health initiatives reach their destinations without administrative delay.
The senators met on June 2, 2025 [1], at the Edward Kennedy Institute in Boston, Massachusetts. During their discussion, they addressed several policy concerns, including the influence of money in Washington, D.C., and the growth of data centers. The pair also discussed Graham Platner as part of their broader conversation on governance and bipartisanship.
Central to their meeting was a shared concern regarding the National Institutes of Health. In their joint communication, the senators focused on the necessity of timely funding for medical research and public health. "We urge the NIH director to accelerate the disbursement of congressionally appropriated funds," Fetterman and McCormick said.
While the meeting focused on policy, it also addressed political speculation. Senator McCormick clarified that there have been no discussions regarding a change in party affiliation. "I have never talked to Senator Fetterman about switching parties," McCormick said.
The collaboration between the two senators serves as a public demonstration of their intent to find common ground on issues affecting Pennsylvania and the broader U.S. economy. Their focus on the NIH suggests a shared priority in maintaining the pace of scientific innovation and the delivery of federal resources.
“"We urge the NIH director to accelerate the disbursement of congressionally appropriated funds,"”
The joint effort by Fetterman and McCormick indicates a strategic focus on administrative accountability within federal health agencies. By bypassing party lines to pressure the NIH, the senators are leveraging bipartisan visibility to resolve funding bottlenecks that can stall medical research and economic growth in their home state.
